Company intelligence / Profile preview

Toku

Bellingham, Washington, USA

Ownership: Private
Development stage: Other

Overview

TOKU-E manufactures and supplies novel antibiotics and antimicrobials for life science research, including applications in cell biology, microbiology, virology, stem cell therapy, and cancer research[1][3][5]. Their mission focuses on simplifying research workflows, but there is no published clinical trial data available.

Therapeutic areas: Infectious DiseasesOther
Modalities: Small moleculeAntibioticAntimicrobial
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Toku.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toku.

Explore the full profile